BioMed Research International

BioMed Research International / 2016 / Article

Retraction | Open Access

Volume 2016 |Article ID 2514067 |

BioMed Research International, "Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies", BioMed Research International, vol. 2016, Article ID 2514067, 1 page, 2016.

Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies

Received16 Mar 2016
Accepted16 Mar 2016
Published31 Mar 2016

The article titled “The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies” [1] has been retracted as it was found to contain a substantial amount of material, without referencing, from the following published article: “Potential of immunotherapy for hepatocellular carcinoma,” by Ekaterina Breous and Robert Thimme, in Journal of Hepatology. The author list has been corrected to remove Salvatore Gruttadauria, Isidoro Di Carlo, Adriana Toro and Alessandra Mangia, who were not involved in the preparation or submission of this article and should not have been listed as authors. The first author, Gaetano Bertino, accepts full responsibility and apologizes to the journal and the other authors. The rest of the authors are not culpable in this plagiarism and are victims of this action.


  1. G. Bertino, S. Demma, A. Ardiri et al., “The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies,” BioMed Research International, vol. 2015, Article ID 731469, 12 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.